Skip to main content
Premium Trial:

Request an Annual Quote

Genedata Imagence 2.0

Genedata has released Genedata Imagence 2.0, the latest version of its enterprise software high-content screening image analysis. The new version offers full end-to-end automation, reducing the time spent on image analysis by an order of magnitude. It enables the analysis of complex phenotypic assay formats without extensive expert input, and the transfer of gained knowledge to new experimental setups. It has also been further optimized for use of distributed computing resources. In particular, the parallelization of image analysis steps results in massive time and cost savings, the company said. Similar to other components of the Genedata Biopharma Platform, the new software can be deployed using on-demand cloud computing service providers like Amazon Web Services.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.